Screener
Bristol-Myers Squibb BMY Q2 2026 earnings
Reported July 30, 2026 · Before market open
Revenue$13.0BBeat by $1.2B
EPS$2.04Beat by $0.44
Revenue estimate$11.7B
EPS estimate$1.60
Next report
Oct 29, 2026 (In 3 weeks)Revenue estimate$12.6B
EPS estimate$1.68
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Bristol-Myers Squibb report Q2 2026 earnings?
- Bristol-Myers Squibb (BMY) reported Q2 2026 earnings on July 30, 2026 before market open.
- What were Bristol-Myers Squibb's Q2 2026 revenue and EPS?
- Bristol-Myers Squibb reported revenue of $13.0B and eps of $2.04 for Q2 2026.
- Did Bristol-Myers Squibb beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $11.7B by $1.2B. EPS beat the consensus estimate of $1.60 by $0.44.
- How did Bristol-Myers Squibb's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 5.7% from $12.3B a year earlier and eps grew 39.7% from $1.46.
- Where can I find Bristol-Myers Squibb's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0000014272-26-000018) and the 10-Q periodic report (0000014272-26-000020) directly on SEC EDGAR. The filing index links above go to sec.gov.
